Effect Of Extracorporeal Shock Wave Therapy On Ultrasonography Changes In Patients With Palmar Fibromatosis: A Randomized Controlled Trial

Not Applicable

Not yet recruiting

Interventions: Other: traditional treatment
Other: Extracorporeal Shock Wave Therapy

Brief Summary: this study will be conducted to investigate the effect of extracorporeal shock wave therapy on ultrasonography chnges In patients with palmar fibromatosis

Detailed Description: Palmar fibromatosis, also known as Dupuytren's contracture, is a condition that affects the hand and fingers. It is characterized by the thickening and tightening of the fascia, a layer of connective tissue beneath the skin of the palm. This thickening and tightening can lead to the formation of nodules or cords that restrict the movement of the affected fingers. The treatment options for palmar fibromatosis vary depending on the severity of the condition and its impact on hand function. Mild cases may not require immediate treatment but should be regularly monitored. However, if the symptoms worsen or hinder hand function, there are several treatment options available. Extracorporeal shock wave therapy (ESWT) is a non-invasive physical therapy procedure that uses high-energy sound waves to treat various musculoskeletal conditions. It is commonly used to manage pain and promote healing in conditions such as plantar fasciitis, tendinitis, calcific tendinitis, and other similar disorders The ESWT has shown promising results in reducing pain, improving function, and promoting healing in various musculoskeletal conditions. sixty patients with palmar fibromatosis will be assigned randomly to two groups; first one will receive extracorporeal shock wave with traditional therapy and the other one will receive traditional therapy only

Recruitment & Eligibility

Inclusion Criteria

Patients diagnosed with palmar fibromatosis.
Adults aged 18 to 70 years.
Patients of any stage of physiological change of the disease (nodules cords and contractures).

Exclusion Criteria

Patients with contraindications to extracorporeal shock wave therapy.
Patients with a history of previous surgery for palmar fibromatosis.
Patients with comorbidities or conditions that may affect the outcomes of the study.
Patients of ganglions and palmar tendon fibrosis.
Patients of sever and morbid obesity.
End stage disease with psychological disturbance nature.
Pregnant women.
Cardiac and pulmonary unstable patients may affect results.

Arm && Interventions

Group	Intervention	Description
traditional treatment	traditional treatment	patients will receive traditional treatment three times a week for six weeks
Extracorporeal Shock Wave Therapy	Extracorporeal Shock Wave Therapy	patients will receive Extracorporeal Shock Wave Therapy and traditional treatment three times a week for six weeks
Extracorporeal Shock Wave Therapy	traditional treatment	patients will receive Extracorporeal Shock Wave Therapy and traditional treatment three times a week for six weeks

Primary Outcome Measures

Name	Time	Method
thickness of lesion	up to six weeks	Ultrasonography will be used to assess the thickness of lesion

Secondary Outcome Measures

Name	Time	Method
pressure pain threshold	up to six weeks	algometer will be used to assess pressure pain threshold
finger range of motion	up to six weeks	goniometer will be used to assess finger range of motion
Disabilities of the Arm, Shoulder, and Hand	up to six weeks	The Arabic version of the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire will be administered to evaluate functional outcomes.The questionnaire consists of 11 items related to daily activities and symptoms. Each item is rated on a 5-point Likert scale, with higher scores indicating greater disability
hand grip strength	up to six weeks	Jamar hand held dynamometer will be used to assess hand grip strength

Receive instant email notifications about changes in this clinical trial

Receive instant email notifications about changes in this clinical trial